Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Andrx Altocor Will Test “Guerilla” Marketing In Cholesterol Market

Executive Summary

Andrx is confident that it can establish the cholesterol agent Altocor with a sales force of less than 300

You may also be interested in...



Andrx Altocor Sales Force Expands 50%; Generic Prilosec Charge Is $41 Mil.

Andrx plans to increase its sales force to 450 reps to support the cholesterol agent Altocor, CEO Richard Lane said during an Oct. 31 conference call

Andrx Altocor Sales Force Expands 50%; Generic Prilosec Charge Is $41 Mil.

Andrx plans to increase its sales force to 450 reps to support the cholesterol agent Altocor, CEO Richard Lane said during an Oct. 31 conference call

AstraZeneca Crestor Plan: Drop 80 Mg, Submit Lower-Dose Data In Q1

AstraZeneca's updated Crestor NDA will focus on doses of 40 mg and lower following a decision not to seek approval for the 80 mg strength of the cholesterol drug

Related Content

UsernamePublicRestriction

Register

LL1133546

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel